The stock of Third Harmonic Bio Inc (THRD) has gone down by -4.66% for the week, with a 28.49% rise in the past month and a 15.46% rise in the past quarter. The volatility ratio for the week is 8.13%, and the volatility levels for the past 30 days are 7.95% for THRD. The simple moving average for the past 20 days is 4.69% for THRD’s stock, with a 35.08% simple moving average for the past 200 days.
Is It Worth Investing in Third Harmonic Bio Inc (NASDAQ: THRD) Right Now?
The 36-month beta value for THRD is also noteworthy at 2.72. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for THRD is 16.24M, and at present, short sellers hold a 4.20% of that float. The average trading volume of THRD on April 24, 2024 was 136.37K shares.
THRD) stock’s latest price update
Third Harmonic Bio Inc (NASDAQ: THRD)’s stock price has gone decline by -5.15 in comparison to its previous close of 11.65, however, the company has experienced a -4.66% decrease in its stock price over the last five trading days. Zacks Investment Research reported 2023-12-29 that Does Third Harmonic Bio, Inc. (THRD) have what it takes to be a top stock pick for momentum investors? Let’s find out.
Analysts’ Opinion of THRD
Many brokerage firms have already submitted their reports for THRD stocks, with Jefferies repeating the rating for THRD by listing it as a “Hold.” The predicted price for THRD in the upcoming period, according to Jefferies is $3.60 based on the research report published on December 16, 2022 of the previous year 2022.
Morgan Stanley, on the other hand, stated in their research note that they expect to see THRD reach a price target of $5. The rating they have provided for THRD stocks is “Equal-Weight” according to the report published on December 15th, 2022.
Morgan Stanley gave a rating of “Overweight” to THRD, setting the target price at $34 in the report published on October 10th of the previous year.
THRD Trading at 9.91% from the 50-Day Moving Average
After a stumble in the market that brought THRD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.03% of loss for the given period.
Volatility was left at 7.95%, however, over the last 30 days, the volatility rate increased by 8.13%, as shares surge +26.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.39% upper at present.
During the last 5 trading sessions, THRD fell by -4.66%, which changed the moving average for the period of 200-days by +99.46% in comparison to the 20-day moving average, which settled at $10.67. In addition, Third Harmonic Bio Inc saw 0.73% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at THRD starting from Holles Natalie C., who sale 13,558 shares at the price of $12.19 back on Apr 11 ’24. After this action, Holles Natalie C. now owns 1,218,836 shares of Third Harmonic Bio Inc, valued at $165,214 using the latest closing price.
Person Julie, the CHIEF ADMINISTRATIVE OFFICER of Third Harmonic Bio Inc, sale 1,107 shares at $10.00 during a trade that took place back on Apr 04 ’24, which means that Person Julie is holding 0 shares at $11,070 based on the most recent closing price.
Stock Fundamentals for THRD
The total capital return value is set at -0.08. Equity return is now at value -11.05, with -10.70 for asset returns.
Based on Third Harmonic Bio Inc (THRD), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -5.17. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -7.67.
Currently, EBITDA for the company is -43.92 million with net debt to EBITDA at 11.92. The liquidity ratio also appears to be rather interesting for investors as it stands at 50.29.
Conclusion
In summary, Third Harmonic Bio Inc (THRD) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
